These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 12671893)

  • 1. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
    Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
    Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
    Gonzalez-Rey E; Delgado M
    Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.
    González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
    Gastroenterology; 2009 Mar; 136(3):978-89. PubMed ID: 19135996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic action of ghrelin in a mouse model of colitis.
    Gonzalez-Rey E; Chorny A; Delgado M
    Gastroenterology; 2006 May; 130(6):1707-20. PubMed ID: 16697735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4.
    Arranz A; Juarranz Y; Leceta J; Gomariz RP; Martínez C
    Peptides; 2008 Jun; 29(6):948-56. PubMed ID: 18359536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of VIP on TLR2 and TLR4 expression in lymph node immune cells during TNBS-induced colitis.
    Arranz A; Abad C; Juarranz Y; Torroba M; Rosignoli F; Leceta J; Gomariz RP; Martínez C
    Ann N Y Acad Sci; 2006 Jul; 1070():129-34. PubMed ID: 16888154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
    Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
    Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
    Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates T helper cell type 1-mediated colitis in mice.
    Daniel C; Radeke HH; Sartory NA; Zahn N; Zuegel U; Steinmeyer A; Stein J
    J Pharmacol Exp Ther; 2006 Nov; 319(2):622-31. PubMed ID: 16914561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cDNA array analysis of cytokines, chemokines, and receptors involved in the development of TNBS-induced colitis: homeostatic role of VIP.
    Abad C; Juarranz Y; Martinez C; Arranz A; Rosignoli F; García-Gómez M; Leceta J; Gomariz RP
    Inflamm Bowel Dis; 2005 Jul; 11(7):674-84. PubMed ID: 15973123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting delivery of anti-TNFalpha oligonucleotide into activated colonic macrophages protects against experimental colitis.
    Zuo L; Huang Z; Dong L; Xu L; Zhu Y; Zeng K; Zhang C; Chen J; Zhang J
    Gut; 2010 Apr; 59(4):470-9. PubMed ID: 19951904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal peptide as a healing mediator in Crohn's disease.
    Arranz A; Abad C; Juarranz Y; Leceta J; Martinez C; Gomariz RP
    Neuroimmunomodulation; 2008; 15(1):46-53. PubMed ID: 18667799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with bindarit, an inhibitor of MCP-1 synthesis, protects mice against trinitrobenzene sulfonic acid-induced colitis.
    Bhatia M; Landolfi C; Basta F; Bovi G; Ramnath RD; de Joannon AC; Guglielmotti A
    Inflamm Res; 2008 Oct; 57(10):464-71. PubMed ID: 18827968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
    Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
    Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
    Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
    Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease.
    Bourreille A; Doubremelle M; de la Blétière DR; Segain JP; Toquet C; Buelow R; Galmiche JP
    Scand J Gastroenterol; 2003 May; 38(5):526-32. PubMed ID: 12795464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-(3', 4'-dimethoxycinnamonyl) anthranilic acid alleviated experimental colitis by inhibiting autoimmune response and inducing CD4+ CD25+ regulatory T cells production.
    Wen Q; Zhou L; Chen H; Zhang Y
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1330-8. PubMed ID: 23663055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide reduces 2,4,6-trinitrobenzene sulfonic acid-induced murine colitis via nuclear factor-κB down-regulation and caspase-3 activation.
    Singer M; Trugnan G; Chelbi-Alix MK
    Innate Immun; 2011 Aug; 17(4):365-74. PubMed ID: 20693187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
    Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
    Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis.
    Bai A; Ma AG; Yong M; Weiss CR; Ma Y; Guan Q; Bernstein CN; Peng Z
    Biochem Pharmacol; 2010 Dec; 80(11):1708-17. PubMed ID: 20797389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.